GlassScriptPhysician profile
Anthony C Edwards
NPI 1962656140
$1,025.48
in general payments reported to CMS, 2019-2025
24 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $131 · 2023: $221 · 2024: $109 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $161.60 | 2022-2025 | Iovera, Zilretta, Exparel |
| Endo Pharmaceuticals INC. | $156.34 | 2021-2024 | Xiaflex |
| Boston Scientific Corporation | $97.74 | 2021-2025 | Wavewriter Alpha Prime 16, General - Erectile Dysfunction |
| Globus Medical, INC. | $90.65 | 2021-2024 | Proximal Tibia Plate, Distal Femur Plate System, Cerclage Cable Fixation |
| Radius Health, INC. | $64.88 | 2021 | |
| Endo USA, INC. | $61.55 | 2024-2025 | Xiaflex |
| Medtronic, INC. | $58.16 | 2022-2024 | Kyphon Express II Kyphopak Tray, Accurian |
| Sonex Health, INC. | $30.00 | 2025 | Sx-One Microknife |
| Heron Therapeutics, INC. | $26.94 | 2021 | |
| Bioventus LLC | $25.24 | 2021-2022 | |
| Horizon Therapeutics Plc | $24.88 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $22.71 | 2025 | |
| Convatec INC. | $20.63 | 2025 | |
| Pacira Therapeutics, INC. | $20.50 | 2021 | |
| Abbott Laboratories | $20.48 | 2025 | Eterna |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $19.97 | 2021 | |
| Nevro Corp. | $19.30 | 2023 | Senza |
| Kowa Pharmaceuticals America, INC. | $18.27 | 2023 | Seglentis |
| Medacta USA, INC. | $17.37 | 2021 | |
| Smith+Nephew, INC. | $15.63 | 2025 | Pico |
| Mimedx Group, INC. | $13.85 | 2025 | |
| Si-Bone, INC. | $13.72 | 2025 | |
| Fidia Pharma USA INC. | $12.87 | 2022 | |
| Orthogenrx INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.